Cravacin (Deucravacitinib) is a tyrosine kinase 2 (TYK2) inhibitor indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
-
5 Postari
-
1 Fotografii
-
0 Video
-
Traieste in 191/1, Bir Uttam Mir Shawkat SarakTejgaon C/A,Dhaka-1208, Bangladesh
-
Male
-
Urmarit de 0 people
Recent Actualizat
-
Generic Ruxolitinib Topical Treatment for Eczema & VitiligoSkin conditions like atopic dermatitis (eczema) and vitiligo are more than just cosmetic concerns; they impact confidence, comfort, and quality of life. For years, patients relied on corticosteroids, which often came with risks of skin thinning and other side effects. The medical field has since evolved, introducing JAK inhibitors as a revolutionary way to treat these conditions at their...0 Commentarii 0 Distribuiri 683 Views 0 previzualizareVă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
Ventoxen (Venetoclax): Targeted Cancer Therapy for CLL & AMLIn the rapidly evolving landscape of oncology, the shift from broad-spectrum treatments to precision medicine has redefined hope for patients. Among the most significant breakthroughs in recent years is Ventoxen (Venetoclax). As a highly specialized cancer therapy, Ventoxen offers a targeted approach to treating specific hematological malignancies, namely Chronic Lymphocytic Leukemia (CLL) and...0 Commentarii 0 Distribuiri 657 Views 0 previzualizare
-
Affordable Resiliva (Resmetirom) for NASH Fibrosis – Buy OnlineNon-alcoholic steatohepatitis (NASH), now increasingly referred to as Metabolic Dysfunction-Associated Steatohepatitis (MASH), has long been a challenge for the medical community. For years, patients struggling with liver inflammation and advancing fibrosis had few direct treatment options beyond lifestyle changes. However, the introduction of Resmetirom, marketed under the brand name Resiliva,...0 Commentarii 0 Distribuiri 577 Views 0 previzualizare
-
Cravacin (Deucravacitinib) 6mg: Generic TYK2 Inhibitor for PsoriasisThe landscape of plaque psoriasis treatment has witnessed a revolutionary shift with the introduction of TYK2 inhibitors. For millions of individuals living with moderate-to-severe plaque psoriasis, the daily struggle involves managing itchy, scaly, and often painful skin lesions. While topical creams and traditional systemic treatments have long been the standard, many patients seek a more...0 Commentarii 0 Distribuiri 544 Views 0 previzualizare
-
0 Commentarii 0 Distribuiri 438 Views 0 previzualizare
Mai multe povesti